Cumberland Pharmaceuticals Financial Overview
Cumberland Pharmaceuticals's market cap is currently $65.96M. The company's EPS TTM is $-0.13; its P/E ratio is -18.66; Cumberland Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
